Literature DB >> 22678979

Opposite roles of LPA1 and LPA3 on cell motile and invasive activities of pancreatic cancer cells.

Kohei Kato1, Kyohei Yoshikawa, Eriko Tanabe, Misaho Kitayoshi, Rie Fukui, Nobuyuki Fukushima, Toshifumi Tsujiuchi.   

Abstract

Lysophosphatidic acid (LPA) interacts with at least six G protein-coupled transmembrane LPA receptors. Recently, it has been demonstrated that each LPA receptor acts as a positive or negative regulator of cellular function. In the present study, to assess a biological role of LPA receptors on cell migration of pancreatic cancer cells, we generated LPA receptor-1 (LPA(1)) and LPA(3) knockdown cells from hamster pancreatic cancer cells by transfection with short hairpin RNA plasmids and measured their cell motile and invasive abilities. In cell motility and invasion assay, a Cell Culture Insert, coated with or without a Matrigel, was used. While the cell motility and invasion of Lpar1 knockdown cells were markedly enhanced than those of control cells, Lpar3 knockdown cells showed significantly lower cell motility and invasion. Moreover, to investigate an involvement of LPA(1) and LPA(3) in the development of pancreatic cancers, we also measured the expression levels of Lpar1 and Lpar3 genes in hamster pancreatic duct adenocarcinomas (PDAs) induced by a nitroso compound. The expressions of Lpar1 gene in PDAs were significantly lower than those in normal pancreatic tissues. By contrast, the elevated expressions of Lpar3 gene were detected in PDAs. We thus demonstrate that LPA(1) and LPA(3) play the different roles on cell migration ability of pancreatic cancer cells, suggesting the opposite effects via LPA(1) and LPA(3) may contribute to the pathogenesis of pancreatic cancers in hamsters.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22678979     DOI: 10.1007/s13277-012-0433-0

Source DB:  PubMed          Journal:  Tumour Biol        ISSN: 1010-4283


  27 in total

Review 1.  Lysophosphatidic acid receptors.

Authors:  J J Contos; I Ishii; J Chun
Journal:  Mol Pharmacol       Date:  2000-12       Impact factor: 4.436

2.  Overexpression of edg-2/vzg-1 induces apoptosis and anoikis in ovarian cancer cells in a lysophosphatidic acid-independent manner.

Authors:  T Furui; R LaPushin; M Mao; H Khan; S R Watt; M A Watt; Y Lu; X Fang; S Tsutsui; Z H Siddik; R C Bast; G B Mills
Journal:  Clin Cancer Res       Date:  1999-12       Impact factor: 12.531

3.  Differential expressions and DNA methylation patterns of lysophosphatidic acid receptor genes in human colon cancer cells.

Authors:  Megumu Tsujino; Minako Fujii; Kyoko Okabe; Toshio Mori; Nobuyuki Fukushima; Toshifumi Tsujiuchi
Journal:  Virchows Arch       Date:  2010-10-03       Impact factor: 4.064

4.  Rapid production of pancreatic carcinoma by initiation with N-nitroso-bis(2-oxopropyl)amine and repeated augmentation pressure in hamsters.

Authors:  K Mizumoto; M Tsutsumi; A Denda; Y Konishi
Journal:  J Natl Cancer Inst       Date:  1988-12-07       Impact factor: 13.506

5.  Induction of lysophosphatidic acid receptor-3 by 12-O-tetradecanoylphorbol-13-acetate stimulates cell migration of rat liver cells.

Authors:  Kyoko Okabe; Kohei Kato; Miki Teranishi; Mai Okumura; Rie Fukui; Toshio Mori; Nobuyuki Fukushima; Toshifumi Tsujiuchi
Journal:  Cancer Lett       Date:  2011-06-24       Impact factor: 8.679

6.  Homo- and hetero-dimerization of LPA/S1P receptors, OGR1 and GPR4.

Authors:  Alexander Zaslavsky; Lisam Shanjukumar Singh; Haiyan Tan; Huawen Ding; Zicai Liang; Yan Xu
Journal:  Biochim Biophys Acta       Date:  2006-08-30

7.  A lysophosphatidic acid receptor lacking the PDZ-binding domain is constitutively active and stimulates cell proliferation.

Authors:  Shinya Shano; Kazuki Hatanaka; Shinsuke Ninose; Ryutaro Moriyama; Toshifumi Tsujiuchi; Nobuyuki Fukushima
Journal:  Biochim Biophys Acta       Date:  2007-12-05

Review 8.  Lysophosphatidic acid production and action: critical new players in breast cancer initiation and progression.

Authors:  N Panupinthu; H Y Lee; G B Mills
Journal:  Br J Cancer       Date:  2010-03-16       Impact factor: 7.640

9.  Aberrant expression of lysophosphatidic acid (LPA) receptors in human colorectal cancer.

Authors:  Dai Shida; Toshiaki Watanabe; Junken Aoki; Kotaro Hama; Joji Kitayama; Hirofumi Sonoda; Yasuhiro Kishi; Hironori Yamaguchi; Shin Sasaki; Akihiro Sako; Tsuyoshi Konishi; Hiroyuki Arai; Hirokazu Nagawa
Journal:  Lab Invest       Date:  2004-10       Impact factor: 5.662

Review 10.  Lysophospholipid receptors: signaling and biology.

Authors:  Isao Ishii; Nobuyuki Fukushima; Xiaoqin Ye; Jerold Chun
Journal:  Annu Rev Biochem       Date:  2004       Impact factor: 23.643

View more
  11 in total

1.  Lysophosphatidic acid receptor-5 negatively regulates cell motile and invasive activities of human sarcoma cell lines.

Authors:  Yan Dong; Miku Hirane; Mutsumi Araki; Nobuyuki Fukushima; Kanya Honoki; Toshifumi Tsujiuchi
Journal:  Mol Cell Biochem       Date:  2014-03-28       Impact factor: 3.396

Review 2.  Role of Silymarin in Cancer Treatment: Facts, Hypotheses, and Questions.

Authors:  Tomas Koltai; Larry Fliegel
Journal:  J Evid Based Integr Med       Date:  2022 Jan-Dec

3.  Expressions of lysophosphatidic acid receptors in the development of human ovarian carcinoma.

Authors:  Jinge Si; Yuanyuan Su; Yifeng Wang; You-Liang Yan; Ya-Ling Tang
Journal:  Int J Clin Exp Med       Date:  2015-10-15

4.  Lysophosphatidic acid stimulates activation of focal adhesion kinase and paxillin and promotes cell motility, via LPA1-3, in human pancreatic cancer.

Authors:  Yan Liao; Ganggang Mu; Lingli Zhang; Wei Zhou; Jun Zhang; Honggang Yu
Journal:  Dig Dis Sci       Date:  2013-09-24       Impact factor: 3.199

Review 5.  Regulation of tumor cell - Microenvironment interaction by the autotaxin-lysophosphatidic acid receptor axis.

Authors:  Gabor J Tigyi; Junming Yue; Derek D Norman; Erzsebet Szabo; Andrea Balogh; Louisa Balazs; Guannan Zhao; Sue Chin Lee
Journal:  Adv Biol Regul       Date:  2018-09-16

Review 6.  Lipid Phosphate Phosphatases and Cancer.

Authors:  Xiaoyun Tang; David N Brindley
Journal:  Biomolecules       Date:  2020-09-02

Review 7.  Role of lysophosphatidic acid and its receptors in health and disease: novel therapeutic strategies.

Authors:  Luiz Henrique Medeiros Geraldo; Tânia Cristina Leite de Sampaio Spohr; Rackele Ferreira do Amaral; Anna Carolina Carvalho da Fonseca; Celina Garcia; Fabio de Almeida Mendes; Catarina Freitas; Marcos Fabio dosSantos; Flavia Regina Souza Lima
Journal:  Signal Transduct Target Ther       Date:  2021-02-01

8.  2-Carba-lysophosphatidic acid is a novel β-lysophosphatidic acid analogue with high potential for lysophosphatidic acid receptor activation and autotaxin inhibition.

Authors:  Keiko Fukasawa; Mari Gotoh; Akiharu Uwamizu; Takatsugu Hirokawa; Masaki Ishikawa; Yoshibumi Shimizu; Shinji Yamamoto; Kensuke Iwasa; Keisuke Yoshikawa; Junken Aoki; Kimiko Murakami-Murofushi
Journal:  Sci Rep       Date:  2021-08-30       Impact factor: 4.379

Review 9.  KAI1/CD82 gene and autotaxin-lysophosphatidic acid axis in gastrointestinal cancers.

Authors:  Shuo Wang; Jiang Chen; Xiao-Zhong Guo
Journal:  World J Gastrointest Oncol       Date:  2022-08-15

Review 10.  Lysophosphatidic Acid Receptor Antagonists and Cancer: The Current Trends, Clinical Implications, and Trials.

Authors:  Yu-Hsuan Lin; Yueh-Chien Lin; Chien-Chin Chen
Journal:  Cells       Date:  2021-06-29       Impact factor: 6.600

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.